Quality by Design Approach for Development and Characterization of Granisetron Hydrochloride-Loaded Orodispersible Films

Granisetron hydrochloride can be used to prevent and treat nausea and vomiting induced by chemotherapy. Its prolonged half-life and reduced dose requirement improve patient acceptance. However, patients undergoing chemotherapy often suffer from dysphagia and drug spitting due to emesis. Hence, the d...

Full description

Saved in:
Bibliographic Details
Main Authors: Ming-Yan Li (Author), Bing Wang (Author), Jun-Qi Zhang (Author), Liu-Liu Yang (Author), Jun-Tao He (Author), Fang Chen (Author)
Format: Book
Published: Georg Thieme Verlag KG, 2023-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_0123bb2c20f5416b9cdc97de3d8dbc59
042 |a dc 
100 1 0 |a Ming-Yan Li  |e author 
700 1 0 |a Bing Wang  |e author 
700 1 0 |a Jun-Qi Zhang  |e author 
700 1 0 |a Liu-Liu Yang  |e author 
700 1 0 |a Jun-Tao He  |e author 
700 1 0 |a Fang Chen  |e author 
245 0 0 |a Quality by Design Approach for Development and Characterization of Granisetron Hydrochloride-Loaded Orodispersible Films 
260 |b Georg Thieme Verlag KG,   |c 2023-12-01T00:00:00Z. 
500 |a 2628-5088 
500 |a 2628-5096 
500 |a 10.1055/s-0043-1777043 
520 |a Granisetron hydrochloride can be used to prevent and treat nausea and vomiting induced by chemotherapy. Its prolonged half-life and reduced dose requirement improve patient acceptance. However, patients undergoing chemotherapy often suffer from dysphagia and drug spitting due to emesis. Hence, the development of a patient-centered formulation of granisetron hydrochloride with simple medication and high compliance is crucial. The current study employed a polymer combination of polyvinylpyrrolidone/polyvinyl alcohol (PVP/PVA) as film-forming materials and Lycoat® RS 780 as a disintegrant to formulate orodispersible films (ODFs) loaded with granisetron hydrochloride. Guided by the concept of quality by design, the quality target product profile and critical quality attributes (CQAs) for the ODF were defined. Through the quality risk assessment, essential factors that have a significant impact on CQAs were identified. The formulation was screened using the Box-Behnken statistical design with three factors and three levels. Our data suggested that all ODF formulations exhibited a disintegration time of less than 60 seconds and complete dissolution within 5 minutes. Furthermore, the formulation displayed appropriate mechanical properties, water residue, and pH values. Thus, the granisetron hydrochloride-loaded ODF is regarded as a patient-friendly formulation that enhances compliance and consequently aids in therapeutic effectiveness. 
546 |a EN 
690 |a granisetron hydrochloride 
690 |a orodispersible films 
690 |a quality by design 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutical Fronts, Vol 05, Iss 04, Pp e297-e309 (2023) 
787 0 |n http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1777043 
787 0 |n https://doaj.org/toc/2628-5088 
787 0 |n https://doaj.org/toc/2628-5096 
856 4 1 |u https://doaj.org/article/0123bb2c20f5416b9cdc97de3d8dbc59  |z Connect to this object online.